For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Precigen Inc (NASDAQ: PGEN) was $1.80 for the day, up 3.45% from the previous closing price of $1.74. In other words, the price has increased by $3.45 from its previous closing price. On the day, 1.13 million shares were traded. PGEN stock price reached its highest trading level at $1.81 during the session, while it also had its lowest trading level at $1.72.
Ratios:
Our analysis of PGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.63 and its Current Ratio is at 1.63. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.
KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 527164160 and an Enterprise Value of 504282368. For the stock, the TTM Price-to-Sale (P/S) ratio is 133.12 while its Price-to-Book (P/B) ratio in mrq is 9.52. Its current Enterprise Value per Revenue stands at 127.248 whereas that against EBITDA is -5.611.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.60, which has changed by 0.29496408 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 17.10%, while the 200-Day Moving Average is calculated to be 45.60%.
Shares Statistics:
PGEN traded an average of 2.09M shares per day over the past three months and 1263130 shares per day over the past ten days. A total of 292.87M shares are outstanding, with a floating share count of 162.74M. Insiders hold about 44.43% of the company’s shares, while institutions hold 25.98% stake in the company. Shares short for PGEN as of 1740700800 were 21571396 with a Short Ratio of 10.34, compared to 1738281600 on 19037437. Therefore, it implies a Short% of Shares Outstanding of 21571396 and a Short% of Float of 11.2399995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
